Industries

 

Biotechnology

Stratagem IPM was originally founded to serve clients in the exciting and emerging biotechnology industry and established pharmaceutical sectors. Many of the original clients remain with Stratagem today having recognised the value of the strong management of their intellectual portfolios.

The UK biotechnology sector remains first in Europe and second only to the USA with many successful companies established and flourishing. Stratagem has contributed to many of these companies from management of the intellectual property portfolios and assistance through due diligence, to leadership in licensing of technology or active participation in acquisition activities. Stratagem continues to actively support this vital sector for Britain by working with the BioIndustry Association, in particular as co-sponsor of the BIA Fledgling Club, which provides unique and vital support for start-up businesses in this sector.

The accumulated knowledge and experience within Stratagem means that maximum value and benefit can be created for any biotechnology company at any stage of development.

[top]

Pharmaceutical

The unique Stratagem approach is used by pharmaceutical companies at all levels of development from start-up to major multinationals.

For smaller companies Stratagem can act as the in-house intellectual property team and grow and develop as the business grows. This versatile service adapts to meet the company needs and can include portfolio construction and development, interim management, specific internal staff training, database management and full document/formalities management.  Stratagem currently provides services for those, including virtual companies, who are seeking a commercial exploitation route through a development partner and/or trade sale.  Stratagem attorneys and support staff have sound and extensive experience in business development and in the in-licensing and commercial exploitation of products and associated intellectual property, together with the relevant technological experience.

Larger pharmaceutical companies and multi-nationals make full use of the wide ranging services to augment or substitute for internal resources. Stratagem can act as an extension of internal departments offering complete service for specific projects or providing temporary or interim resources to cover for staff absence or peaks of activity.

Most of the Stratagem principal attorneys have extensive experience of working with major pharmaceutical companies as do most of the support team.

[top]

Diagnostics, Medical Devices and Healthcare

From Stratagem’s origins, it was a natural extension into diagnostics and general healthcare which has resulted in successful involvement in a wide diversity of businesses, including needleless injection, CPR, stents and numerous diagnostic assays.

Stratagem has assisted medical device companies in securing intellectual property assets from the UK and elsewhere and in doing so have been an integral part of the clients’ activities in developing their business plans, through technology in-licensing and commercial out-licensing, mergers, and trade acquisitions. Stratagem takes an active role in both the preparation and implementation stages of such strategies.

Key Stratagem attorneys and support staff have extensive experience in business development, licensing and the commercial leverage provided by intellectual property in the exploitation of products in these markets, together with relevant technological experience in fields such as materials, sensing chemistry, instrumentation, microfluidics and biochemistry which provides excellent coverage of this multidisciplinary field. 

In this area in particular the Stratagem approach of specifically advising on preferred options and actively leading implementation has delivered major benefits for the clients.

[top]

Veterinary

Stratagem IPM has an enviable track record with a range of companies and individuals working in the veterinary field. This extends from experience with cell research for specific veterinary applications to complex licensing strategies and negotiations in others. If the business is at any stage of development ranging from basic research to sophisticated device or prototype development, the unique Stratagem approach can add value. Past experience and specific commercial knowledge of the veterinary field makes Stratagem the first choice partner for management of any veterinary intellectual property assets.

[top]

Cleantech

The global drive to reduce carbon emissions has already generated a new wave of technology-based companies which are developing products for the generation of clean energy and its efficient distribution, low energy consumption devices, and materials recycling and reuse processes for industry. The science of bio- and nano-technology and new materials is supporting this long wave of development.  At this stage however establishment of a strong intellectual property position is essential for new cleantech companies.  Stratagem sees this field as one of strategic importance which it is well placed to support.  The staff has an extensive range of relevant expertise including materials, fine and petrochemicals, biology, chemistry, biochemistry, devices, and automotive engineering.

The full catalogue of Stratagem services is relevant for growth companies in this sector, where the need for joined-up technology underpins the whole idea of a commercially successful carbon reduction proposition. The Stratagem experience in business development, partnering and commercial exploitation, licensing and due diligence is proving valuable to the existing clients.  Additionally Stratagem can provide the more traditional areas of patent and trademark protection and portfolio management for any cleantech company.

[top]

Oil, Gas and Petrochemicals

Despite much research and development in this field being undertaken by the large multinational companies there are numerous start-up and emerging companies in the field with huge potential. Such companies have proven to benefit from the Stratagem experience in the biotechnology and pharmaceutical industries where at times “David meets Goliath” and the small companies need protection and support in dealing with the multinationals. Stratagem is well placed to assist, with client’s requirements ranging from provision of interim resources to complete out-sourcing of specific intellectual property portfolios. As a result key staff have developed excellent contacts and experience which will benefit any client seeking solutions to short or longer term assignments.

[top]

Polymers, Paints and Coatings

Although a mature industry, the rise of nanotechnology and the need for highly functional materials in medical science, fuel cells, and displays amongst many others is spurring a renaissance in the development of new polymers, composites and their use, particularly as coatings, in technically demanding applications. In patenting terms these fields may be congested and obtaining best protection for new compositions and their application is a critical aspect.  Stratagem’s scientific experience covers fields in the chemical industries such as these.

[top]

Commodity, Specialty Chemicals and Electrochemistry

The professional team at Stratagem includes qualified staff able to bring commercially focussed knowledge and experience to the general and specialty chemical industries. With even the largest of companies increasingly seeking added value through enhancement or rationalisation of their intellectual property assets, the Stratagem approach brings rapid cost effective results.  This is of interest to those with limited availability of in-house intellectual property staff, either larger companies with fully occupied staff who wish to unlock value from parts of their portfolio by seeking a commercialisation partner or purchaser, or smaller organisations seeking to exploit new chemistry but who are unable to support an in-house intellectual property function. 

Stratagem have sound and extensive experience in business development and the commercial exploitation of chemical products and associated intellectual property, together with the relevant technological experience.

[top]

Light engineering

Engineering industries have consistently been a rich source of innovative intellectual property. In recent years companies have selected Stratagem IPM, who are especially active in communications support, aerospace and security engineering. Patent enforcement is often a key service in this area.

Routinely the Stratagem staff are assisting those with no or minimal in-house intellectual property function, who are seeking a commercial exploitation route, for example through a development and/or commercialisation partner or purchaser, because of Stratagem’s sound and extensive experience in business development and the commercial exploitation of products and associated intellectual property and in carrying out intellectual property due diligence, together with the relevant technological experience. 

[top]

Nanotechnology

Since the 1980’s methods for developing materials and devices by design at the atomic and molecular scale have grown steadily. These tools have now enabled the application of nanotechnology to solving real commercial problems. Applications have been found in diverse fields such as functional materials for textiles and fuel cells, optoelectronic devices for communication, lighting, photovoltaics and medical implants. 

Nanotechnology spans the disciplines of physics, chemistry and biology, but has its own unique methodology which integrates these subjects at a fundamental level. In patent terms this makes it a complex subject to protect.  Stratagem can bring together staff experienced in all these fields together with highly experienced attorneys to obtain the best protection for these inventions.  Stratagem can identify the commercially important elements and ensure through the course of filing and prosecution that the scope of the patent is aligned with the commercial strategy. Stratagem can develop an understanding of the competitors’ intellectual property activities and advise on how threats and opportunities can be managed to ensure that the business value grows.

[top]